
Aspera Biomedicines Launches Second ADAR1p150 Crystallization Study to ISS on SpaceX CRS-34
Aspera Biomedicines Successfully Launches Second ADAR1p150 Protein Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34 Aspera Biomedicines Inc., a biotechnology company focused on developing first-in-class therapies targeting cancer stem cells, has successfully launched its second ADAR1p150 protein crystallization…












